Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00194168 · ClinicalTrials.gov registry record
Ectopic Pregnancy Biomarkers
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 1,306
- Enrollment target
NCT00194168: Completed study, sponsored by University of Pennsylvania.
NCT00194168 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 1,306 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00194168 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 1,306 participants
- Enrollment target
Study Summary
In an attempt to simplify the diagnosis of ectopic pregnancy, the researchers will investigate the presence of specific molecular markers of ectopic pregnancy. The quantification of these (and other proteins) will be performed using the Ciphergen Protein Chip system where serum is sampled with a high-throughput system. The patterns of these peaks will be compared for those with a diagnosis of ectopic pregnancy and normal pregnancy. Later goals of the research will be to identify the actual proteins that correspond to the peaks which discriminate between the two clinical entitles. The goal is to identify a unique protein pattern or protein peak to distinguish a normal intrauterine pregnancy from that of an ectopic implanted gestation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,306 participants |
| Start Date | 2000-06 |
| Est. Completion | 2013-11 |
What the finished NCT00194168 record still lists
NCT00194168 is an observational study that tracks outcomes without assigning an intervention. Its 1,306 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00194168 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00194168 about?
NCT00194168 is a clinical study titled "Ectopic Pregnancy Biomarkers". In an attempt to simplify the diagnosis of ectopic pregnancy, the researchers will investigate the presence of specific molecular markers of ectopic pregnancy. The quantification of these (and other proteins) will be performed using the Ciphergen Protein Chip system where serum is sampled with a hig...
What is the current status of trial NCT00194168?
This trial is currently completed. The enrollment target is 1,306 participants. The study started on 2000-06. Estimated completion is 2013-11.
Who is sponsoring clinical trial NCT00194168?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06517901 · 1,306 participants · NA
Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer
- NCT04171323 · 1,305 participants · NA
The Active Mind Trial: An Adaptive Randomized Trial to Improve Function and Delay Dementia
- NCT06136624 · 1,310 participants · Phase 3
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
- NCT06556433 · 1,312 participants · NA
Family-Based Financial Incentives Intervention for Smoking Cessation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia